Skip to main content
. 2011 Nov 8;7(5):918–922. doi: 10.5114/aoms.2011.25573

Table I.

Expression of selected markers of the primary and metastatic (mesenteric and colonic) tumours

Marker Tumour (intensity/% of area; localization)
EGFR Primary
Mesenteric
Colonic: sarcomatoid field
Colonic: thecomatous field +/75; C
WT1 Primary +/10; C
Mesentery +/5; C
Colonic: sarcomatoid field ++/30; +++/20; C
Colonic: thecomatous field
Bcl2 Primary +/1; C
Mesentery
Colonic: sarcomatoid field ++/20; C
Colonic: thecomatous field
ERβ Primary +/70; C, N
Mesentery +/35; ++/50; C, N
Colonic: sarcomatoid field ++/70; C, N
Colonic: thecomatous field ++/100; C, N
Fascin Primary +++/90; C
Mesentery ++/45; +++/40; C
Colonic: sarcomatoid field +/10; ++/50; +++/30; C
Colonic: thecomatous field +/50; C

C – cytoplasmic staining, N – nuclear staining. Staining intensity was scored as follows: negative –, weak +, moderate ++, and strong +++